-
1 Comment
OUE Lippo Healthcare Limited is currently in a long term uptrend where the price is trading 10.1% above its 200 day moving average.
From a valuation standpoint, the stock is 7.4% more expensive than other stocks from the Healthcare sector with a price to sales ratio of 9.1.
OUE Lippo Healthcare Limited's total revenue rose by 97.0% to $10M since the same quarter in the previous year.
Its net income has dropped by 3724.6% to $-97M since the same quarter in the previous year.
Finally, its free cash flow grew by 119.8% to $584K since the same quarter in the previous year.
Based on the above factors, OUE Lippo Healthcare Limited gets an overall score of 3/5.
| CurrencyCode | SGD |
|---|---|
| ISIN | SG2F86994413 |
| Exchange | SG |
| Sector | Healthcare |
| Industry | Medical Care Facilities |
| Market Cap | 111M |
|---|---|
| PE Ratio | None |
| Target Price | None |
| Beta | 0.17 |
| Dividend Yield | None |
OUE Healthcare Limited, an investment holding company, owns, operates, and invests in healthcare businesses in Singapore, China, Myanmar, Indonesia, and Japan. It operates through Healthcare Operations, Healthcare Assets, Properties Under Development, and Investments segments. The company is involved in the operation of hospitals and clinics; supply of medical equipment and pharmaceutical products; and rental of investment properties and owned assets. It also engages in the development of medical facilities, healthcare-related assets, and integrated mixed-used projects; and investment in real estate investment trusts and properties. The company was formerly known as OUE Lippo Healthcare Limited and changed its name to OUE Healthcare Limited in April 2023. The company was founded in 2010 and is headquartered in Singapore. OUE Healthcare Limited is a subsidiary of Treasure International Holdings Pte Ltd.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 5WA.SG using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
